Navigation Links
Warner Chilcott to Present at Wachovia's 19th Annual Mid-Year Equity Conference
Date:6/19/2009

ARDEE, Ireland, June 19 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will present at Wachovia's 19th Annual Mid-Year Equity Conference on Wednesday, June 24, 2009 at 2:30 p.m. ET. Presenting for Warner Chilcott will be Rochelle Fuhrmann, Senior Director, Investor Relations.

Warner Chilcott's presentation will be webcast live for all interested parties at www.wcrx.com under the Investor Relations tab. An archived version of the webcast will be available for two weeks following the live presentation.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare and dermatology segments of the U.S. pharmaceuticals market. The Company is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G


'/>"/>
SOURCE Warner Chilcott Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Senators Webb and Warner Vote to Protect Americas Kids From Tobacco
2. Warner Chilcott to Present at the Goldman Sachs 30th Annual Healthcare Conference
3. Warner Chilcott Announces FDA Acceptance of NDA Submission for Low Dose Oral Contraceptive
4. Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2009 and Updates 2009 Full Year Guidance
5. Warner Chilcott Proposes Redomestication From Bermuda to Ireland
6. Warner Chilcott to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
7. Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
8. HBO, Warner Bros. Employee Initiatives and the Alzheimers Association, California Southland Chapter Present a Free, Public, Advance Screening of THE ALZHEIMERS PROJECT: Caregivers
9. Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2009 Financial Results
10. Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
11. Warner Chilcott Announces Receipt of FDA Response to Citizen Petition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: